Search

Home > Lung Cancer Considered > Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance
Podcast: Lung Cancer Considered
Episode:

Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance
Category: Science & Medicine
Duration: 00:45:50
Publish Date: 2025-02-11 14:00:07
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib. Guest: Dr. Yasushi Goto from National Cancer Center, Japan in Tokyo Guest: Dr. Rachel Sanborn, the Earle A. Chiles Research Institute of the Providence Cancer Institute in Portland, Oregon
Total Play: 0